• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Laser mammography moves toward PMA

Article

Imaging Diagnostic Systems' hopes of joining the mammography sweepstakes are pinned on its computed tomography laser mammography (CTLM) system gaining FDA premarket approval next year.IDS in Plantation, FL, has been developing its system for several

Imaging Diagnostic Systems' hopes of joining the mammography sweepstakes are pinned on its computed tomography laser mammography (CTLM) system gaining FDA premarket approval next year.

IDS in Plantation, FL, has been developing its system for several years. It hopes to complete the PMA process early in 2001. Another company, Advanced Research and Technology (ART) of Montreal, is working on a similar system, called SoftScan.

Both SoftScan and IDS's CTLM system train the laser energy on one side of the breast and place a detector on the other side to catch the photons after they pass through the tissue.

The ART system uses a stationary light source to create 2-D images, whereas CTLM's lasers rotate around the breast to create 3-D tomographic images. ART likewise hopes to clear the FDA in 2001 and begin marketing its product in 2002.

Both systems are considered adjuncts to x-ray mammography. n

Recent Videos
Computed Tomography Study Shows Emergence of Silicosis in Engineered Stone Countertop Workers
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
Related Content
© 2024 MJH Life Sciences

All rights reserved.